• COMPANY
    • Company
    • Leadership
    • Partnership & Collaboration
    • Location
  • TECHNOLOGY
    • Platform Technology
  • PIPELINE
    • Pipeline
    • Cancer Stemness Blocking Agents
    • IBD Therapeutic Agents
    • 3rd Generation Immuno-Therapeutic Agents
  • IR/PR
    • News
    • Notice
    • IR
  • Careers
    • Talents
    • Join us
  • CONTACT US
    • ENG
    • KOR

COMPANY

  • Company
  • Leadership
  • Partnership & Collaboration
  • Location

TECHNOLOGY

  • Platform Technology

PIPELINE

  • Pipeline
  • Cancer Stemness Blocking Agents
  • IBD therapeutics
  • 3rd Generation Immuno-Therapeutic Agents

IR/PR

  • News
  • Notice
  • IR

Careers

  • Talents
  • Join us

COMPANY

  • Company
  • Leadership
  • Partnership & Collaboration
  • Location

TECHNOLOGY

  • Platform Technology

PIPELINE

  • Pipeline
  • Cancer Stemness Blocking Agents
  • IBD therapeutics
  • 3rd Generation Immuno-Therapeutic Agents

IR/PR

  • News
  • Notice
  • IR

Careers

  • Talents
  • Join us

IR/PR

  • News
  • Notice
  • IR
  • News
    2024.09.02
    PIMEDBIO - JLABS Korea is Rapidly Energizing the Local Innovation Ecos..
  • News
    2024.03.20
    [Nature] PIMEDBIO selected KDDF’s top 10 innovative tasks
  • News
    2023.12.15
    PIMEDBIO Top 10 new drug developers in 2023
1
ADDRESS.
2F H2233,172, Dolma-ro, Bundang-gu, Seongnam-si, Gyeonggi-do, Republic of Korea 13605
TEL.
+82-31-8039-7240
FAX.
+82-50-4001-4874
EMAIL.
info@pimedbio.com

(C) 2020. Pimedbio Inc. All rights reserved.